The Future of Healthcare in Singapore. the Challenges and Benefits of Integrated Use of Industry 4.0 Technologies and How Likely the General Public and Institutions Are to Adopt the Integration of Industry 4.0 Technologies

Abstract

Industry 4.0 in the pharmaceutical, medical devices, and healthcare sectors could have a significant impact as they can help maximize productivity by analyzing the data of patients. This is helpful as different medical technologies can be used concurrently. The application of Industry 4.0 technologies to the pharma, medical, and healthcare sectors may also play an important role in addressing and helping overcome the COVID-19 pandemic, thanks to the latest innovations in the space of biopharma and biotech.As Ow (2021b) discussed and explored how medical industries in Singapore can utilize Artificial Intelligence, Blockchain, Digital health, Internet of Medical Things (IoMT), and Telemedicine as part of the future of the digital health evolution. As Ow( 2021c) also gathered feedback from both the industries and the general public and discussed the common utilization of medical data for digital health, the likelihood to share the information with their employers, and the willingness to subscribe to a platform that houses their data protected by encrypted codes that can only be accessed with the patients' explicit consent.This study aims to gather perspectives from both the industries and the general public and discuss the challenges and benefits of the combined use of innovation 4.0 technologies and digital health in Singapore's medical industries are likely to deliver.This research will also examine how likely medical industries will adopt the integration of industry 4.0 technologies and the full integration of Artificial Intelligence, Blockchain, Internet of Medical Things, Digital Health, and Telemedicine to elevate their competitiveness, improve doctor-patient relationships, and to sustain innovation. This study will also examine how receptive the public is to adopting these technologies, integrating technologies into the healthcare industry, and the future of digital health. Using qualitative methodology, this research is exploratory in nature, given the early-stage developments in the implementation of integrated 4.0 technologies in the digital health space. In addition, this study aims to assess the future potential benefits of integrating these advanced technologies into the medical and biopharma industries for the healthcare system of Singapore and its citizens. Finally, this study will seek to contribute to the existing literature in the fields of digital health, Blockchain-based health devices, Internet of Medical Things (IoMT), and Telemedicine, and to the integrated use of these technologies to create new value innovation opportunities and business models in the rapidly expanding digital health space of Singapore.